CBD significantly decreased pain and increased mobility in a dose-dependent fashion in dogs with osteoarthritis (OA), according to a recent study at the Baylor College of Medicine. This finding is consistent with earlier work by Cornell University researchers who also found that CBD “significantly” decreased pain and increased activity in dogs with OA. Importantly, both studies report that CBD did not produce any ill effects in the dogs.
There’s an interesting wrinkle to the Baylor study. They found that it was more effective to administer CBD with fat than without it: “Liposomal CBD (20 mg/day) was as effective as the highest dose of non-liposomal CBD (50 mg/day) in improving clinical outcomes.”
The authors conclude that the success of CBD as a therapeutic for OA in dogs warrants follow-up investigations in humans. The Arthritis Foundation, the largest arthritis advocacy group in the US, would agree. Last year they became the first major health organization to issue CBD guidelines. And they did so on the strength of their experience with the elderly where they found that CBD was “very effective” or “effective” for almost ¾ of people who suffered from arthritis.